NCT05505435View on ClinicalTrials.gov

Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

653

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Contraception
Interventions
DRUG

Depot-Medroxyprogestereone Acetate

subcutaneous depot medroxyprogesterone acetate

DRUG

Depot-Medroxyprogestereone Acetate

intramuscular depot medroxyprogesterone acetate

Trial Locations (1)

60661

RECRUITING

Family Planning Associates, Chicago

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Northwestern University

OTHER